Pharmacological treatment of hip fractured patients in Italy

A simulation based on Tuscany regional database for the TARGET project

Prisco Piscitelli, Alessia Metozzi, Maria Luisa Brandi, Ranuccio Nuti, Carla Rizzuti, Elisa Orlandini, Loredano Giorni, Daniela Merlotti

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Italy is the Country with the highest life expectancy in the world, and over 75,000 elderly people experience a hip fracture each year. Objective: following the Tuscany TARGET protocol, we aimed to estimate the costs of pharmacological treatment in the hypothesis of treating all elderly Italian people with hip fractures. Methods: we analyzed the Tuscany healthcare system databases at the beginning of the Tuscany TARGET project for the prevention of hip fractures in elderly patients, and the Italian national hospitalizations records and DRGs databases concerning hip fractures occurred between 2000 and 2005. Results: costs sustained for pharmacological treatments effective in reducing the risk of subsequent hip fractures all over Italy would account for 17.5 million Euros, representing only 0.18% of the overall national pharmaceuticals expenditures, while the national healthcare service is currently spending more than 30% of the overall pharmaceuticals expenditures in providing cardiovascular-active drugs. Conclusions: The burden of hip fractures in the Italian elderly population is substantial and must be acknowledged as an important health problem. Specific preventive strategies, such as the Tuscany TARGET project should be implemented in all Italian regions.

Original languageEnglish
Pages (from-to)140-143
Number of pages4
JournalClinical Cases in Mineral and Bone Metabolism
Volume7
Issue number2
Publication statusPublished - May 2010

Fingerprint

Hip Fractures
Italy
Hip
Databases
Pharmacology
Health Expenditures
Therapeutics
Delivery of Health Care
Cardiovascular Agents
Diagnosis-Related Groups
Life Expectancy
Pharmaceutical Preparations
Health Care Costs
Hospitalization
Costs and Cost Analysis
Health
Population

Keywords

  • Compliance
  • Costs
  • Hip fractures
  • Incidence
  • Osteoporosis
  • Treatment

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Piscitelli, P., Metozzi, A., Brandi, M. L., Nuti, R., Rizzuti, C., Orlandini, E., ... Merlotti, D. (2010). Pharmacological treatment of hip fractured patients in Italy: A simulation based on Tuscany regional database for the TARGET project. Clinical Cases in Mineral and Bone Metabolism, 7(2), 140-143.

Pharmacological treatment of hip fractured patients in Italy : A simulation based on Tuscany regional database for the TARGET project. / Piscitelli, Prisco; Metozzi, Alessia; Brandi, Maria Luisa; Nuti, Ranuccio; Rizzuti, Carla; Orlandini, Elisa; Giorni, Loredano; Merlotti, Daniela.

In: Clinical Cases in Mineral and Bone Metabolism, Vol. 7, No. 2, 05.2010, p. 140-143.

Research output: Contribution to journalArticle

Piscitelli, P, Metozzi, A, Brandi, ML, Nuti, R, Rizzuti, C, Orlandini, E, Giorni, L & Merlotti, D 2010, 'Pharmacological treatment of hip fractured patients in Italy: A simulation based on Tuscany regional database for the TARGET project', Clinical Cases in Mineral and Bone Metabolism, vol. 7, no. 2, pp. 140-143.
Piscitelli, Prisco ; Metozzi, Alessia ; Brandi, Maria Luisa ; Nuti, Ranuccio ; Rizzuti, Carla ; Orlandini, Elisa ; Giorni, Loredano ; Merlotti, Daniela. / Pharmacological treatment of hip fractured patients in Italy : A simulation based on Tuscany regional database for the TARGET project. In: Clinical Cases in Mineral and Bone Metabolism. 2010 ; Vol. 7, No. 2. pp. 140-143.
@article{44f375d2111846da9eb2f84261acbdec,
title = "Pharmacological treatment of hip fractured patients in Italy: A simulation based on Tuscany regional database for the TARGET project",
abstract = "Background: Italy is the Country with the highest life expectancy in the world, and over 75,000 elderly people experience a hip fracture each year. Objective: following the Tuscany TARGET protocol, we aimed to estimate the costs of pharmacological treatment in the hypothesis of treating all elderly Italian people with hip fractures. Methods: we analyzed the Tuscany healthcare system databases at the beginning of the Tuscany TARGET project for the prevention of hip fractures in elderly patients, and the Italian national hospitalizations records and DRGs databases concerning hip fractures occurred between 2000 and 2005. Results: costs sustained for pharmacological treatments effective in reducing the risk of subsequent hip fractures all over Italy would account for 17.5 million Euros, representing only 0.18{\%} of the overall national pharmaceuticals expenditures, while the national healthcare service is currently spending more than 30{\%} of the overall pharmaceuticals expenditures in providing cardiovascular-active drugs. Conclusions: The burden of hip fractures in the Italian elderly population is substantial and must be acknowledged as an important health problem. Specific preventive strategies, such as the Tuscany TARGET project should be implemented in all Italian regions.",
keywords = "Compliance, Costs, Hip fractures, Incidence, Osteoporosis, Treatment",
author = "Prisco Piscitelli and Alessia Metozzi and Brandi, {Maria Luisa} and Ranuccio Nuti and Carla Rizzuti and Elisa Orlandini and Loredano Giorni and Daniela Merlotti",
year = "2010",
month = "5",
language = "English",
volume = "7",
pages = "140--143",
journal = "Clinical Cases in Mineral and Bone Metabolism",
issn = "1724-8914",
publisher = "CIC Edizioni Internazionali s.r.l.",
number = "2",

}

TY - JOUR

T1 - Pharmacological treatment of hip fractured patients in Italy

T2 - A simulation based on Tuscany regional database for the TARGET project

AU - Piscitelli, Prisco

AU - Metozzi, Alessia

AU - Brandi, Maria Luisa

AU - Nuti, Ranuccio

AU - Rizzuti, Carla

AU - Orlandini, Elisa

AU - Giorni, Loredano

AU - Merlotti, Daniela

PY - 2010/5

Y1 - 2010/5

N2 - Background: Italy is the Country with the highest life expectancy in the world, and over 75,000 elderly people experience a hip fracture each year. Objective: following the Tuscany TARGET protocol, we aimed to estimate the costs of pharmacological treatment in the hypothesis of treating all elderly Italian people with hip fractures. Methods: we analyzed the Tuscany healthcare system databases at the beginning of the Tuscany TARGET project for the prevention of hip fractures in elderly patients, and the Italian national hospitalizations records and DRGs databases concerning hip fractures occurred between 2000 and 2005. Results: costs sustained for pharmacological treatments effective in reducing the risk of subsequent hip fractures all over Italy would account for 17.5 million Euros, representing only 0.18% of the overall national pharmaceuticals expenditures, while the national healthcare service is currently spending more than 30% of the overall pharmaceuticals expenditures in providing cardiovascular-active drugs. Conclusions: The burden of hip fractures in the Italian elderly population is substantial and must be acknowledged as an important health problem. Specific preventive strategies, such as the Tuscany TARGET project should be implemented in all Italian regions.

AB - Background: Italy is the Country with the highest life expectancy in the world, and over 75,000 elderly people experience a hip fracture each year. Objective: following the Tuscany TARGET protocol, we aimed to estimate the costs of pharmacological treatment in the hypothesis of treating all elderly Italian people with hip fractures. Methods: we analyzed the Tuscany healthcare system databases at the beginning of the Tuscany TARGET project for the prevention of hip fractures in elderly patients, and the Italian national hospitalizations records and DRGs databases concerning hip fractures occurred between 2000 and 2005. Results: costs sustained for pharmacological treatments effective in reducing the risk of subsequent hip fractures all over Italy would account for 17.5 million Euros, representing only 0.18% of the overall national pharmaceuticals expenditures, while the national healthcare service is currently spending more than 30% of the overall pharmaceuticals expenditures in providing cardiovascular-active drugs. Conclusions: The burden of hip fractures in the Italian elderly population is substantial and must be acknowledged as an important health problem. Specific preventive strategies, such as the Tuscany TARGET project should be implemented in all Italian regions.

KW - Compliance

KW - Costs

KW - Hip fractures

KW - Incidence

KW - Osteoporosis

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=78449240177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449240177&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 140

EP - 143

JO - Clinical Cases in Mineral and Bone Metabolism

JF - Clinical Cases in Mineral and Bone Metabolism

SN - 1724-8914

IS - 2

ER -